An emerging therapy for tendinopathy and degenerative joint disease is worth consideration.
The following articles have the tag osteoarthritis
A NEW consensus statement will help doctors match osteoarthritis (OA) patients to appropriate NSAIDs according to risk of gastrointestinal (GI) side effects, an international expert committee says.
LIFESTYLE strategies, particularly diet for weight loss, suitable exercise and thermal modalities (cold pack) play an important role in the prevention and management of patients with osteoarthritis (OA).1,2
A NEW study adds weight to the evidence that taking a chondroitin and glucosamine supplement is just as effective for treating severe pain associated with knee osteoarthritis as the widely used anti-inflammatory drug celecoxib.
Investigation and management of a swollen knee will flow from the history of its onset.
AUSTRALIANS with rheumatoid arthritis (RA) are not being diagnosed early enough with many people missing out treatments that could potentially stop the disease from progressing, a survey shows.
THE future may be read from the palm of your hand, but to find out if your future holds knee replacement surgery it seems your fingers could reveal all.
MORE than one in five middle-aged to elderly Australians are taking glucosamine, a study shows.
A SYDNEY GP division’s partnership with local doctors and fitness providers has been so successful it is set to expand.
GLUCOSAMINE is no better than placebo for osteoarthritis, according to a leading Australian rheumatologist.
GPs commonly face big barriers in assisting patients to achieve the lifestyle modifications necessary to manage osteoarthritis (OA), a survey shows.
KNEE implants are the latest prosthetic device to come under scrutiny, with claims there is little or no evidence of safety and cost-effectiveness for many on the market.
PATIENTS with osteoarthritis (OA) are being urged to continue using glucosamine supplements if they wish, despite a study showing the supplement does not alleviate painful symptoms. The study published in the British Medical Journal found glucosamine, chondroitin, or a combination of both, were no more beneficial than a placebo. The Swiss meta-analysis compared the results of 10 trials conducted on 3803 patients. “Compared with placebo, glucosamine, chondroitin and their combination do not reduce joint pain or have an impact on narrowing of joint space,” said study authors from the institute of social and preventive medicine at the University ...
A decade ago, atrial fibrillation was considered an emerging epidemic – has it now reached its peak? Kate Woods looks at the rise and rise of AF.